These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 30939936)
1. Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report. Gonzales M; Pipalia A; Weil A J Investig Med High Impact Case Rep; 2019; 7():2324709619832324. PubMed ID: 30939936 [TBL] [Abstract][Full Text] [Related]
3. HIT in the head: a systematic review of cerebral venous sinus thrombosis in classical and autoimmune heparin-induced thrombocytopenia. Bauman MMJ; Naylor RM; Wijdicks EF J Thromb Thrombolysis; 2021 Oct; 52(3):952-961. PubMed ID: 34089462 [TBL] [Abstract][Full Text] [Related]
7. Intravenous Immunoglobulin (IVIG) in Severe Heparin-Induced Thrombocytopenia (HIT) in a Traumatic Brain Injury (TBI) Patient with Cerebral Venous Sinus Thrombosis (CVST). Buckley NA; Baskaya MK; Darsie ME Neurocrit Care; 2021 Jun; 34(3):1103-1107. PubMed ID: 33000379 [No Abstract] [Full Text] [Related]
8. Autoimmune heparin-induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin. Arcinas LA; Manji RA; Hrymak C; Dao V; Sheppard JI; Warkentin TE Transfusion; 2019 Jun; 59(6):1924-1933. PubMed ID: 30903805 [TBL] [Abstract][Full Text] [Related]
9. Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology. Choi PY; Uzun G; Bakchoul T; J Thromb Haemost; 2024 Jun; 22(6):1772-1778. PubMed ID: 38301999 [TBL] [Abstract][Full Text] [Related]
10. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review. Warkentin TE Expert Rev Hematol; 2019 Aug; 12(8):685-698. PubMed ID: 31274032 [No Abstract] [Full Text] [Related]
11. Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura. Al-Riyami AZ; Lee J; Connolly M; Shereck E Pediatr Blood Cancer; 2011 Jul; 57(1):157-9. PubMed ID: 21445949 [TBL] [Abstract][Full Text] [Related]
12. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome. Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806 [TBL] [Abstract][Full Text] [Related]
13. Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis. Ahmad S; Untch B; Haas S; Hoppensteadt DA; Misselwitz F; Messmore HL; Walenga JM; Fareed J Mol Cell Biochem; 2004 Mar; 258(1-2):163-70. PubMed ID: 15030181 [TBL] [Abstract][Full Text] [Related]
14. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review. Shih AW; Sheppard JI; Warkentin TE Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208 [TBL] [Abstract][Full Text] [Related]
15. Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review. Dougherty JA; Yarsley RL Ann Pharmacother; 2021 Feb; 55(2):198-215. PubMed ID: 32693627 [TBL] [Abstract][Full Text] [Related]
16. IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia. Padmanabhan A; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Bryant BJ; Alperin JB; Deloughery TG; Mulvey KP; Dhakal B; Wen R; Wang D; Aster RH Chest; 2017 Sep; 152(3):478-485. PubMed ID: 28427966 [TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia. Park BD; Kumar M; Nagalla S; De Simone N; Aster RH; Padmanabhan A; Sarode R; Rambally S Transfus Apher Sci; 2018 Aug; 57(4):561-565. PubMed ID: 30244713 [TBL] [Abstract][Full Text] [Related]
18. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban. Manji F; Warkentin TE; Sheppard JI; Lee A Platelets; 2020; 31(1):124-127. PubMed ID: 31397594 [TBL] [Abstract][Full Text] [Related]